Last updated on February 2018

Ziv-aflibercept Efficacy in Better Regulating AMD

Brief description of study

This is a randomized, open-label, interventional, controlled study to determine the effects of Zaltrap on Neovascularized Wet Macular Degeneration as compared to the control anti-vascular endothelial growth factor ("anti-VEGF") injections (bevacizumab, ranibizumab, or aflibercept).

Clinical Study Identifier: NCT03423823

Find a site near you

Start Over

Wagner Macula & Retina Center

Virginia Beach, VA United States
  Connect »